clavulanic acid has been researched along with fosfomycin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Yokota, N | 1 |
| Ariyama, Y; Hirakawa, K; Kaneko, H; Misawa, S; Nakai, H; Nakao, M; Seriu, T; Takashima, T; Tsuda, S; Ueda, Y | 1 |
| Millán Rodríguez, F; Rousaud Barón, A; Rousaud Barón, F | 1 |
| Mitrokhin, SD; Shirokograd, VI; Sokolov, AA; Zabaznyĭ, NP | 1 |
1 trial(s) available for clavulanic acid and fosfomycin
| Article | Year |
|---|---|
[Clinical effects of a combination treatment with fosfomycin and clavulanic acid/ticarcillin for infections in patients complicated with hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Fosfomycin; Hematologic Diseases; Humans; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Ticarcillin | 1994 |
7 other study(ies) available for clavulanic acid and fosfomycin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
[Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. I. The combined effect of arbekacin with fosfomycin or clavulanic acid/ticarcillin].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Dibekacin; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Fosfomycin; Methicillin Resistance; Staphylococcus aureus; Ticarcillin | 1992 |
[Pilot study of coadjuvant treatment of recurrent cystitis in women by means of AM3 (Immnoferon)].
Topics: Adjuvants, Immunologic; Amoxicillin; Calcium Phosphates; Ciprofloxacin; Clavulanic Acid; Cystitis; Drug Evaluation; Drug Therapy, Combination; Escherichia coli Infections; Female; Follow-Up Studies; Fosfomycin; Glycopeptides; Humans; Pilot Projects; Recurrence; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vaginosis, Bacterial | 2003 |
[Comparative study on the efficacy of cefuroxime, amoxycillin/clavulanic acid and fosfomycin in prophylaxis of nosocomial infections in oncologic patients after surgical operations].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Clavulanic Acid; Cross Infection; Female; Fosfomycin; Humans; Male; Middle Aged; Retrospective Studies; Urinary Bladder Neoplasms | 2008 |